Hepatitis B Virus Infection Term Paper by Top Papers

The paper looks at how Papatheodoridis, Manolakopoulos, Dusheiko, and Archimandritis (2008) examined the various treatment options for the treatment of chronic hepatitis B virus (HBV) infection that include standard and pegylated interferon alfa and additional antiviral agents, including lamivudine, adefovir, entecavir, and telbivudine (Papatheodoridis et al., 2007). The paper relates that these treatments can either consist of long-term treatments that aim to maintain remission or therapies of finite duration that attempt to achieve sustained off-therapy responses. The paper discusses how for patients with chronic HBV infection, oral antivirals are the sole long-term treatment. Additionally, the paper notes that Papatheodoridis et al. (2008) reports that viral suppression has a favorable effect on patient's outcome and transforms the natural history and evolution of the illness, thus, viral resistance is the negative aspect of long-term antiviral therapy.